会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 44. 发明申请
    • Anti-Inflammatory Agents
    • 抗炎药
    • US20100016286A1
    • 2010-01-21
    • US11922277
    • 2006-06-14
    • David J. GraingerDavid John Fox
    • David J. GraingerDavid John Fox
    • A61K31/55C40B40/04A61K31/44A61K31/40C07D223/12C07D211/00C07D207/00A61P29/00
    • C07D223/12A61K31/4015A61K31/45A61K31/55C07D207/267C07D207/273C07D211/76
    • The invention provides compounds, pharmaceutical compositions and uses of compounds and salts thereof of general formula (I), for the preparation of a medicament for treatment of an inflammatory disorder, but excluding (S)-3-(r-methylcyclohexyl-carbonylamino)-caprolactam: wherein z is 1, 2, 3 or 4; A is —CO— or —SO2-; Q is linear or branched alkyl, alkenyl, alkynyl, alkoxy, oxyalkyl, aminoalkyl, alkylamino, alkylaminoalkyl, haloalkyl, aryl or substituted aryl; T1 and T2 together constitute a cycloalkyl, cycloalkenyl or polycycloalkyl radical composed of n additional carbon atoms, where n is between 2 and 7; and each hydrogen atom bonded to the carbon atoms in the ring generated by T1 and T2 may be independently be substituted by a group R1, where R1 is independently selected from an alkyl, haloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl or alkylamino radical of 1 to 20 carbon atoms; or each R1 is independently selected from fluoro, chloro, bromo, iodo, hydroxy, oxyalkyl, amino, aminoalkyl or aminodialkyl radical.
    • 本发明提供了通式(I)化合物及其盐的化合物,药物组合物及其用途,用于制备治疗炎症性疾病但不包括(S)-3-(R-甲基环己基 - 羰基氨基) - 己内酰胺:其中z为1,2,3或4; A是-CO-或-SO 2 - ; Q是直链或支链烷基,烯基,炔基,烷氧基,烷氧基,氨基烷基,烷基氨基,烷基氨基烷基,卤代烷基,芳基或取代的芳基; T1和T2一起构成由n个另外的碳原子组成的环烷基,环烯基或多环烷基,其中n在2和7之间; 并且与由T1和T2生成的环中与碳原子键合的每个氢原子可以独立地被基团R 1取代,其中R 1独立地选自烷基,卤代烷基,烷氧基,卤代烷氧基,烯基,炔基或烷基氨基 至20个碳原子; 或每个R 1独立地选自氟,氯,溴,碘,羟基,氧烷基,氨基,氨基烷基或氨基二烷基。
    • 45. 发明申请
    • Thermo-reversibly gelled colloidal suspensions and a process for making the same
    • 热可逆胶凝胶体悬浮液及其制备方法
    • US20090318309A1
    • 2009-12-24
    • US12386335
    • 2009-04-16
    • Kyle William KimbleJeremy Paul WalkerSanlord Abraham Asher
    • Kyle William KimbleJeremy Paul WalkerSanlord Abraham Asher
    • C40B40/14C40B40/04B01J13/00
    • C40B40/14B01J13/0065
    • Disclosed is a thermoreversible synthesis of a new type of material made by embedding a colloidal population within a thermo-reversibly gelled polymer. The polymer may be a physically cross-linked PVA hydrogel. PVA hydrogels are non-toxic, biocompatible, mechanically robust, and elastic. The present invention TGCCA diffraction is similar to that of photo-polymerized PCCA. The present invention TGCCA can be irreversibly covalently cross-linked using glutaraldehyde. The cross-linked TGCCA can be made responsive to chemical stimuli by functionalizing the hydrogel hydroxyl groups. The diffraction of carboxyl or amine functionalized TGCCA was monitored as a function of the pH and determined diffraction wavelengths titrate with the pKa of the functional group. It was also demonstrated that TGCCA could be fabricated in arbitrarily large volumes and shapes. The present invention method fabricates inexpensive homogenously diffracting chemically modifiable TGCCA.
    • 公开了通过将胶体体嵌入热可逆胶凝聚合物制备的新型材料的热可逆合成。 聚合物可以是物理交联的PVA水凝胶。 PVA水凝胶是无毒的,生物相容的,机械坚固的和弹性的。 本发明TGCCA衍射与光聚合PCCA相似。 本发明TGCCA可以用戊二醛不可逆地共价交联。 通过官能化水凝胶羟基,交联TGCCA可以对化学刺激作出反应。 监测羧基或胺官能化TGCCA的衍射作为pH的函数,并用官能团的pKa测定衍射波长滴定度。 还表明,TGCCA可以以任意大的体积和形状制造。 本发明方法制造廉价的均匀衍射化学修饰的TGCCA。